Bulgaria is again among the stars in the offshoring and outsourcing industry, this time as a popular destination for the pharmaceutical sector.
This is the opinion of experts in the yearbook of the British National Outsourcing Association (NOA).
The country, together with a number of Central European markets continue to attract companies from the pharmaceutical industry with the "multiple benefits" which the region and the individual countries offer.
Increased costs of developing new drugs led companies in the sector to seek better opportunities for offshoring in order to achieve a certain level of profitability in the development of their products on a global level, the report said.